# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Tryp Therapeutics, Inc. (OTCQB: TRYPF) (CSE:TRYP) has submitted an Investigational New Drug application to the U.S.
Tryp Therapeutics Inc. (OTCQB: TRYPF) (CSE:TRYP), a clinical-stage biotechnology company focused on developing intravenous-infu...
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company in the medical psychedelics space, announced it has rece...
Detroit Decriminalizes Psychedelics Detroit is the latest to join the growing list of U.S. cities that have decriminalized psy...
Contents
Cybin Inc.
Michael Pollan’s New Book Takes A Deep Dive Into Mescaline – Will This Be A Turning Point For The Recognition And Study of Mesc...